Covered recipient · General Payments record
KERA LYN BROWNE
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$1,482.76
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $471.23 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $186.35 | 5 |
| Lilly USA, LLC | $71.64 | 3 |
| Insmed, Inc. | $53.42 | 1 |
| Incyte Corporation | $27.92 | 2 |
| ConvaTec Inc. | $26.31 | 1 |
| ABBVIE INC. | $25.99 | 1 |
| PFIZER INC. | $24.49 | 1 |
| Janssen Biotech, Inc. | $19.76 | 1 |
| Dermavant Sciences, Inc. | $17.96 | 1 |
| Biofrontera Inc. | $17.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.99 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106837608 | CMS |
| Amgen Inc. | $8.88 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117515481 | CMS |
| Amgen Inc. | $4.82 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117515483 | CMS |
| Amgen Inc. | $15.88 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117515485 | CMS |
| Amgen Inc. | $149.15 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117515487 | CMS |
| Amgen Inc. | $7.62 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117515489 | CMS |
| Biofrontera Inc. | $17.39 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106607127 | CMS |
| ConvaTec Inc. | $26.31 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151388475 | CMS |
| Dermavant Sciences, Inc. | $17.96 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127958615 | CMS |
| Incyte Corporation | $14.38 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141319077 | CMS |
| Incyte Corporation | $13.54 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141246522 | CMS |
| Insmed, Inc. | $53.42 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089566489 | CMS |
| Janssen Biotech, Inc. | $19.76 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078457801 | CMS |
| Lilly USA, LLC | $18.72 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135770008 | CMS |
| Lilly USA, LLC | $25.74 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135771260 | CMS |
| Lilly USA, LLC | $27.18 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135770006 | CMS |
| PFIZER INC. | $24.49 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131143049 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.